Shining a Light on UV Disinfection

Ultraviolet, more commonly referred to as simply UV, light is gaining popularity as an additional measure offices and schools can take to effectively control and prevent infection indoors in the era of the novel coronavirus.

Dr. Fiona Collins and Dr. Scott Cohen of the HealthFirst Medical Advisory Board joined the HealthFirst podcast to outline the advantages and downsides of major UV technologies seeing more widespread use in the wake of the COVID-19 pandemic.

While different types of UV disinfection technology can effectively disinfect both air and surfaces, the technology is not without its potential downsides. One key consideration is safety, specifically regarding dosage levels and what amount of exposure is safe for occupants of a space.

While high-intensity UV-C solutions can be used in empty rooms to disinfect them rather thoroughly, another common challenge is shadows.

“Typically, what happens is there are two cycles – one in one direction, one in the other, and, sometimes, even more to make sure those shadows are treated,” Cohen said. “You really can’t be exposed to UV-C in this high-intensity fashion. … You cannot be in the room.”

While low-intensity options could be safer, it’s important to understand your space, the specific device and solution you’re looking into, and how to make a space as safe as possible without putting inhabitants in danger.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…